ILC2s-Trailblazers in the Host Response Against Intestinal Helminths

被引:22
作者
Bouchery, Tiffany [1 ]
Le Gros, Graham [2 ]
Harris, Nicola [1 ]
机构
[1] Monash Univ, Dept Immunol & Pathol, AMREP, Melbourne, Vic, Australia
[2] Malaghan Inst Med Res, Allerg & Parasit Dis Programme, Wellington, New Zealand
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
关键词
ILC2; helminth; type; 2; immunity; activation; regulation; tuft cell; neuron; INNATE LYMPHOID-CELLS; TRANSCRIPTION FACTOR GATA3; TYPE-2; IMMUNITY; TUFT CELLS; MAST-CELLS; CHEMOSENSORY CELLS; IFN-GAMMA; T-CELLS; IL-33; PROMOTES;
D O I
10.3389/fimmu.2019.00623
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Group 2 innate lymphoid cells (ILC2s) were first discovered in experimental studies of intestinal helminth infection-and much of our current knowledge of ILC2 activation and function is based on the use of these models. It is perhaps not surprising therefore that these cells have also been found to play a key role in mediating protection against these large multicellular parasites. ILC2s have been intensively studied over the last decade, and are known to respond quickly and robustly to the presence of helminths-both by increasing in number and producing type 2 cytokines. These mediators function to activate and repair epithelial barriers, to recruit other innate cells such as eosinophils, and to help activate T helper 2 cells. More recent investigations have focused on the mechanisms by which the host senses helminth parasites to activate ILC2s. Such studies have identified novel stromal cell types as being involved in this process-including intestinal tuft cells and enteric neurons, which respond to the presence of helminths and activate ILC2s by producing IL-25 and Neuromedin, respectively. In the current review, we will outline the latest insights into ILC2 activation and discuss the requirement for-or redundancy of-ILC2s in providing protective immunity against intestinal helminth parasites.
引用
收藏
页数:12
相关论文
共 32 条
  • [21] HUMORAL RESPONSE AND CHANGES IN IL-2 RECEPTOR'S EXPRESSION AFTER IMMUNISATION OF PIGLETS WITH MATERNAL ANTIBODIES AGAINST AUJESZKY'S DISEASE
    Markowska-Daniel, Iwona
    Pomorska-Mol, Malgorzata
    Bednarek, Dariusz
    BULLETIN OF THE VETERINARY INSTITUTE IN PULAWY, 2009, 53 (02) : 169 - 174
  • [22] A Role for the Chicken Interferon-Stimulated Gene CMPK2 in the Host Response Against Virus Infection
    Li, Xin
    Feng, Yiyi
    Liu, Weiwei
    Tan, Lei
    Sun, Yingjie
    Song, Cuiping
    Liao, Ying
    Xu, Chenggang
    Ren, Tao
    Ding, Chan
    Qiu, Xusheng
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [23] Vaccination against SARS-CoV-2 in Haemodialysis Patients: Spike's Ab Response and the Influence of BMI and Age
    Ponce, Pedro
    Peralta, Ricardo
    Felix, Carla
    Pinto, Carla
    Pinto, Bruno
    Matos, Joao Fazendeiro
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (16)
  • [24] Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus
    Kosanovich, Jessica L.
    Eichinger, Katherine M.
    Lipp, Madeline A.
    Gidwani, Sonal V.
    Brahmbhatt, Devarshi
    Yondola, Mark A.
    Chi, David H.
    Perkins, Timothy N.
    Empey, Kerry M.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [25] IL-7 induces type 2 cytokine response in lung ILC2s and regulates GATA3 and CD25 expression
    Sheikh, Abdalla
    Lu, Julia
    Melese, Etienne
    Seo, Jung Hee
    Abraham, Ninan
    JOURNAL OF LEUKOCYTE BIOLOGY, 2022, 112 (05) : 1105 - 1113
  • [26] Cell therapy with human IL-10-producing ILC2s limits xenogeneic graft-versus-host disease by inhibiting pathogenic T cell responses
    Reid, Kyle T.
    Colpitts, Sarah J.
    Mathews, Jessica A.
    Carreira, Abel Santos
    Murphy, Julia M.
    Borovsky, Dorota T.
    Jegatheeswaran, Sinthuja
    Cui, Wenhui
    Moya, Tommy Alfaro
    Sachewsky, Nadia
    An, James
    Xia, Yubing
    Mortha, Arthur
    Lee, Jong Bok
    Zhang, Li
    Novitzky-Basso, Igor
    Mattsson, Jonas
    Crome, Sarah Q.
    CELL REPORTS, 2025, 44 (01):
  • [27] Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein
    Sengupta, Anirban
    Azharuddin, Mohammad
    Cardona, Maria E.
    Devito, Claudia
    von Castelmur, Eleanore
    Wehlin, Anna
    Pietras, Zuzanna
    Sunnerhagen, Maria
    Selegard, Robert
    Aili, Daniel
    Alamer, Ali
    Hinkula, Jorma
    Al-Otaibi, Noha
    VACCINES, 2022, 10 (04)
  • [28] Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells-A Strategy Used by Coxsackie B Virus to Evade the Host's Innate Immune Response at the Primary Site of Infection?
    Stone, Virginia M.
    Ringqvist, Emma E.
    Larsson, Par G.
    Domsgen, Erna
    Holmlund, Ulrika
    Sverremark-Ekstrom, Eva
    Flodstrom-Tullberg, Malin
    MICROORGANISMS, 2021, 9 (01) : 1 - 16
  • [29] Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2
    Saikh, Kamal U.
    Anam, Khairul
    Sultana, Halima
    Ahmed, Rakin
    Kumar, Simran
    Srinivasan, Sanjay
    Ahmed, Hafiz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [30] Influences of indigenous isolates Pantoea agglomerans RCS2 on growth, proximate analysis, haematological parameters, digestive enzyme activities, serum biochemical parameters, antioxidants activities, intestinal morphology, disease resistance, and molecular immune response in juvenile's cobia fish (Rachycentron canadum)
    Amenyogbe, Eric
    Yang, Er-jun
    Xie, Rui-tao
    Huang, Jian-sheng
    Chen, Gang
    AQUACULTURE, 2022, 551